Device Center Director Advocates Getting “Experimental” With Third-Party
This article was originally published in The Gray Sheet
Executive Summary
The Center for Devices and Radiological Health is looking to assess how third-party and FDA review of 510(k)s compare
You may also be interested in...
CDRH Open To Third-Party Review Of 510(k)s With Clinical Data
CDRH leadership would not oppose a legislative amendment to allow third parties to review 510(k) applications that rely on clinical data, according to center director David Feigal.
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.